Abstract
1. Sumatriptan, a 5-hydroxytryptamine (5-HT)1-like receptor agonist, is effective against the headache of migraine. The effects of sumatriptan injected via the carotid artery on the cerebral microcirculation were studied in 10 anaesthetized cats. 2. The local cerebral blood volume (CBV), mean transit time of blood (MTT) and cerebral blood flow (CBF) in the parieto-temporal cortex were measured by a photoelectric method. CBV represents the cumulative dimensions of the cerebral microvessels. 3. Sumatriptan at 5 and 50 micrograms kg-1 had no significant effects on the CBV, MTT, CBF, and mean arterial blood pressure (MABP); 500 micrograms kg-1 of sumatriptan reduced the CBV, prolonged the MTT, and decreased the CBF (approximately -20%) without affecting the MABP. Sumatriptan, 5 mg kg-1, elicited transient reductions in CBV and CBF, which were attributable to the rapid and marked falls of MABP seen with this dose. 4. Thus, while a high dose of sumatriptan (500 micrograms kg-1) exhibits direct vasoconstrictor actions on the cerebral vessels, low doses of sumatriptan, within the therapeutic range, elicit no vasoconstriction. The data do not support a vasoconstrictor action of sumatriptan playing a primary role in reversing the headache of migraine.
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barzó P., Bari F., Dóczi T., Jancsó G., Bodosi M. Significance of the rate of systemic change in blood pressure on the short-term autoregulatory response in normotensive and spontaneously hypertensive rats. Neurosurgery. 1993 Apr;32(4):611–618. doi: 10.1227/00006123-199304000-00018. [DOI] [PubMed] [Google Scholar]
- Blau J. N. Migraine: A vasomotor instability of the meningeal circulation. Lancet. 1978 Nov 25;2(8100):1136–1139. doi: 10.1016/s0140-6736(78)92287-0. [DOI] [PubMed] [Google Scholar]
- Buzzi M. G., Moskowitz M. A. The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Br J Pharmacol. 1990 Jan;99(1):202–206. doi: 10.1111/j.1476-5381.1990.tb14679.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cady R. K., Wendt J. K., Kirchner J. R., Sargent J. D., Rothrock J. F., Skaggs H., Jr Treatment of acute migraine with subcutaneous sumatriptan. JAMA. 1991 Jun 5;265(21):2831–2835. [PubMed] [Google Scholar]
- Caekebeke J. F., Ferrari M. D., Zwetsloot C. P., Jansen J., Saxena P. R. Antimigraine drug sumatriptan increases blood flow velocity in large cerebral arteries during migraine attacks. Neurology. 1992 Aug;42(8):1522–1526. doi: 10.1212/wnl.42.8.1522. [DOI] [PubMed] [Google Scholar]
- Connor H. E., Feniuk W., Humphrey P. P. Characterization of 5-HT receptors mediating contraction of canine and primate basilar artery by use of GR43175, a selective 5-HT1-like receptor agonist. Br J Pharmacol. 1989 Feb;96(2):379–387. doi: 10.1111/j.1476-5381.1989.tb11828.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Connor H. E., Stubbs C. M., Feniuk W., Humphrey P. P. Effect of sumatriptan, a selective 5-HT1-like receptor agonist, on pial vessel diameter in anaesthetised cats. J Cereb Blood Flow Metab. 1992 May;12(3):514–519. doi: 10.1038/jcbfm.1992.70. [DOI] [PubMed] [Google Scholar]
- Diener H. C., Peters C., Rudzio M., Noe A., Dichgans J., Haux R., Ehrmann R., Tfelt-Hansen P. Ergotamine, flunarizine and sumatriptan do not change cerebral blood flow velocity in normal subjects and migraneurs. J Neurol. 1991 Aug;238(5):245–250. doi: 10.1007/BF00319734. [DOI] [PubMed] [Google Scholar]
- Feniuk W., Humphrey P. P., Perren M. J. The selective carotid arterial vasoconstrictor action of GR43175 in anaesthetized dogs. Br J Pharmacol. 1989 Jan;96(1):83–90. doi: 10.1111/j.1476-5381.1989.tb11787.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Friberg L., Olesen J., Iversen H. K., Sperling B. Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan. Lancet. 1991 Jul 6;338(8758):13–17. doi: 10.1016/0140-6736(91)90005-a. [DOI] [PubMed] [Google Scholar]
- GRODINS F. S. Basic concepts in the determination of vascular volumes by indicator-dilution methods. Circ Res. 1962 Mar;10:429–446. doi: 10.1161/01.res.10.3.429. [DOI] [PubMed] [Google Scholar]
- Goadsby P. J., Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol. 1993 Jan;33(1):48–56. doi: 10.1002/ana.410330109. [DOI] [PubMed] [Google Scholar]
- Goadsby P. J., Zagami A. S., Donnan G. A., Symington G., Anthony M., Bladin P. F., Lance J. W. Oral sumatriptan in acute migraine. Lancet. 1991 Sep 28;338(8770):782–783. doi: 10.1016/0140-6736(91)90666-d. [DOI] [PubMed] [Google Scholar]
- Humphrey P. P., Feniuk W. Mode of action of the anti-migraine drug sumatriptan. Trends Pharmacol Sci. 1991 Dec;12(12):444–446. doi: 10.1016/0165-6147(91)90630-b. [DOI] [PubMed] [Google Scholar]
- Humphrey P. P., Feniuk W., Perren M. J., Beresford I. J., Skingle M., Whalley E. T. Serotonin and migraine. Ann N Y Acad Sci. 1990;600:587–600. doi: 10.1111/j.1749-6632.1990.tb16912.x. [DOI] [PubMed] [Google Scholar]
- Jansen I., Edvinsson L., Mortensen A., Olesen J. Sumatriptan is a potent vasoconstrictor of human dural arteries via a 5-HT1-like receptor. Cephalalgia. 1992 Aug;12(4):202–205. doi: 10.1046/j.1468-2982.1992.1204202.x. [DOI] [PubMed] [Google Scholar]
- Moskowitz M. A. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol Sci. 1992 Aug;13(8):307–311. doi: 10.1016/0165-6147(92)90097-p. [DOI] [PubMed] [Google Scholar]
- Parsons A. A. 5-HT receptors in human and animal cerebrovasculature. Trends Pharmacol Sci. 1991 Aug;12(8):310–315. doi: 10.1016/0165-6147(91)90583-e. [DOI] [PubMed] [Google Scholar]
- Parsons A. A., Whalley E. T., Feniuk W., Connor H. E., Humphrey P. P. 5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery. Br J Pharmacol. 1989 Feb;96(2):434–440. doi: 10.1111/j.1476-5381.1989.tb11835.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Perrin V. L., Färkkilä M., Goasguen J., Doenicke A., Brand J., Tfelt-Hansen P. Overview of initial clinical studies with intravenous and oral GR43175 in acute migraine. Cephalalgia. 1989;9 (Suppl 9):63–72. doi: 10.1111/J.1468-2982.1989.TB00075.X. [DOI] [PubMed] [Google Scholar]
- Scott A. K., Grimes S., Ng K., Critchley M., Breckenridge A. M., Thomson C., Pilgrim A. J. Sumatriptan and cerebral perfusion in healthy volunteers. Br J Clin Pharmacol. 1992 Apr;33(4):401–404. doi: 10.1111/j.1365-2125.1992.tb04058.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tomita M., Gotoh F., Amano T., Tanahashi N., Kobari M., Shinohara T., Mihara B. Transfer function through regional cerebral cortex evaluated by a photoelectric method. Am J Physiol. 1983 Sep;245(3):H385–H398. doi: 10.1152/ajpheart.1983.245.3.H385. [DOI] [PubMed] [Google Scholar]
- Tomita M., Gotoh F., Sato T., Amano T., Tanahashi N., Tanaka K., Yamamoto M. Photoelectric method for estimating hemodynamic changes in regional cerebral tissue. Am J Physiol. 1978 Jul;235(1):H56–H63. doi: 10.1152/ajpheart.1978.235.1.H56. [DOI] [PubMed] [Google Scholar]
- Tomita M., Gotoh F., Tanahashi N., Kobari M., Terayama Y., Mihara B., Ohta K., Gerdsen I. Comparison between the photoelectric method and H2 clearance method for measuring cerebrocortical blood flow in cats. J Cereb Blood Flow Metab. 1988 Oct;8(5):727–732. doi: 10.1038/jcbfm.1988.120. [DOI] [PubMed] [Google Scholar]
- den Boer M. O., Villalón C. M., Heiligers J. P., Humphrey P. P., Saxena P. R. Role of 5-HT1-like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptan. Br J Pharmacol. 1991 Feb;102(2):323–330. doi: 10.1111/j.1476-5381.1991.tb12173.x. [DOI] [PMC free article] [PubMed] [Google Scholar]